Evaluation of Diolaze XL Blended Mode for Hair Removal

Exclusion Criteria

• •Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles.
• •Pregnancy and nursing.
• •Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
• •Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regimen.
• •Poorly controlled endocrine disorders, such as diabetes, thyroid dysfunction, polycystic ovary and hormonal virilization.
• •Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash.
• •History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
• •Severe concurrent conditions, such as cardiac disorders, sensory disturbances.
• •Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
• •Known skin photosensitivity or using drugs increasing skin photosensitivity.
• •Diseases that may be stimulated by light, such as epilepsy, lupus and urticaria.
• •Six months delay is recommended if other recent treatments like light, laser or RF were performed on the same area.
• •Treating over tattoo and permanent make-up.
• •Fresh tan from sun, sunbeds or chemicals or planned excessive sun exposure.
• •Vitiligo.
• •As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient.